These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21070606)

  • 1. L-selectin is dispensable for T regulatory cell function postallogeneic bone marrow transplantation.
    Carlson MJ; Fulton LM; Coghill JM; West ML; Burgents JE; Wan Y; Panoskaltsis-Mortari A; Tedder TF; Blazar BR; Serody JS
    Am J Transplant; 2010 Dec; 10(12):2596-603. PubMed ID: 21070606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD.
    Ermann J; Hoffmann P; Edinger M; Dutt S; Blankenberg FG; Higgins JP; Negrin RS; Fathman CG; Strober S
    Blood; 2005 Mar; 105(5):2220-6. PubMed ID: 15546950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
    Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
    Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease.
    Wysocki CA; Jiang Q; Panoskaltsis-Mortari A; Taylor PA; McKinnon KP; Su L; Blazar BR; Serody JS
    Blood; 2005 Nov; 106(9):3300-7. PubMed ID: 16002422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice.
    Zheng J; Liu Y; Liu Y; Liu M; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
    Sci Transl Med; 2013 Jan; 5(168):168ra9. PubMed ID: 23325802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation.
    Lu SY; Liu KY; Liu DH; Xu LP; Huang XJ
    Clin Exp Immunol; 2011 Aug; 165(2):264-77. PubMed ID: 21635226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic bone marrow grafts with high levels of CD4(+) CD25(+) FoxP3(+) T cells can lead to engraftment failure.
    Fricke S; Rothe K; Hilger N; Ackermann M; Oelkrug C; Fricke C; Schönfelder U; Niederwieser D; Emmrich F; Sack U
    Cytometry A; 2012 Jun; 81(6):476-88. PubMed ID: 22522779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
    Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
    Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Freeze and Thaw of CD4+CD25+Foxp3+ Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease.
    Florek M; Schneidawind D; Pierini A; Baker J; Armstrong R; Pan Y; Leveson-Gower D; Negrin R; Meyer E
    PLoS One; 2015; 10(12):e0145763. PubMed ID: 26693907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHIP limits immunoregulatory capacity in the T-cell compartment.
    Collazo MM; Wood D; Paraiso KH; Lund E; Engelman RW; Le CT; Stauch D; Kotsch K; Kerr WG
    Blood; 2009 Mar; 113(13):2934-44. PubMed ID: 19136659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.
    Taylor PA; Panoskaltsis-Mortari A; Swedin JM; Lucas PJ; Gress RE; Levine BL; June CH; Serody JS; Blazar BR
    Blood; 2004 Dec; 104(12):3804-12. PubMed ID: 15292057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells.
    Scalapino KJ; Daikh DI
    PLoS One; 2009 Jun; 4(6):e6031. PubMed ID: 19551149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses.
    Vogtenhuber C; Bucher C; Highfill SL; Koch LK; Goren E; Panoskaltsis-Mortari A; Taylor PA; Farrar MA; Blazar BR
    Blood; 2010 Jul; 116(3):466-74. PubMed ID: 20442366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease.
    Chen BJ; Cui X; Sempowski GD; Liu C; Chao NJ
    Blood; 2004 Feb; 103(4):1534-41. PubMed ID: 14551132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease.
    Sato K; Eizumi K; Fukaya T; Fujita S; Sato Y; Takagi H; Yamamoto M; Yamashita N; Hijikata A; Kitamura H; Ohara O; Yamasaki S; Saito T; Sato K
    Blood; 2009 May; 113(19):4780-9. PubMed ID: 19228924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.
    Lu SX; Kappel LW; Charbonneau-Allard AM; Atallah R; Holland AM; Turbide C; Hubbard VM; Rotolo JA; Smith M; Suh D; King C; Rao UK; Yim N; Bautista JL; Jenq RR; Penack O; Na IK; Liu C; Murphy G; Alpdogan O; Blumberg RS; Macian F; Holmes KV; Beauchemin N; van den Brink MR
    PLoS One; 2011; 6(7):e21611. PubMed ID: 21760897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7.
    Szanya V; Ermann J; Taylor C; Holness C; Fathman CG
    J Immunol; 2002 Sep; 169(5):2461-5. PubMed ID: 12193715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells.
    Scalapino KJ; Tang Q; Bluestone JA; Bonyhadi ML; Daikh DI
    J Immunol; 2006 Aug; 177(3):1451-9. PubMed ID: 16849451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapy.
    Yarkoni S; Prigozhina TB; Slavin S; Askenasy N
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):523-35. PubMed ID: 22227590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CD4+CD25+highFoxp3+CD62L+ regulatory T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplantation.
    Vela-Ojeda J; Montiel-Cervantes L; Granados-Lara P; Reyes-Maldonado E; García-Latorre E; Garcia-Chavez J; Majluf-Cruz A; Mayani H; Borbolla-Escoboza JR; Esparza MG
    Stem Cells Dev; 2010 Mar; 19(3):333-40. PubMed ID: 19919293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.